Covid-19 Vaccination During Pregnancy in France: a Descriptive Study of Uptake Using the National Healthcare data System
Related Experiment Video
Updated: May 23, 2025

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Elise Quentin1, Ismaïl Ahmed1, Chi-Hong Duong1
1Université Paris-Saclay, UVSQ, Inserm, CESP, High Dimensional Biostatistics for Drug Safety and Genomics, Villejuif, France..
Insights
COVID-19 vaccine uptake during pregnancy in France was lower than in the general population, with only 26% of pregnant women receiving a vaccine during gestation. Targeted campaigns are needed to improve vaccination coverage in pregnant individuals.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Pregnant women and fetuses face elevated risks from SARS-CoV-2 infection.
- Understanding COVID-19 vaccine uptake patterns during pregnancy is crucial for maternal and fetal health.
- France initiated COVID-19 vaccination in late 2020, making timely data collection essential.
Purpose of the Study:
- To assess COVID-19 vaccine uptake among pregnant women in France.
- To analyze vaccination patterns based on socio-demographic factors and calendar time.
- To examine vaccine uptake across different pregnancy stages and in relation to SARS-CoV-2 infection.
Main Methods:
- Utilized national healthcare database records for women ending pregnancy between December 2020 and December 2022.
- Linked vaccination and SARS-CoV-2 infection data.
- Calculated weekly vaccination rates by pregnancy phase, considering periods of ineligibility post-infection.
Main Results:
- Overall vaccine uptake (at least one dose) was 75% in 2021-2022, lower than the general population (90%).
- Only 26% of pregnant women received at least one vaccine dose during pregnancy.
- Lower uptake observed in younger, deprived women, and those in specific French regions.
Conclusions:
- National recommendations positively influenced vaccination dynamics.
- Vaccination predominantly occurred outside pregnancy trimesters, with the second trimester being the most common period during pregnancy.
- Targeted campaigns are recommended to enhance vaccine coverage in pregnant populations.
Abstract:
Pregnant women and their fetus are at increased risk of complications when infected by SARS-CoV-2. This study describes COVID-19 vaccine uptake during pregnancy in France (i) according to socio-demographic characteristics, and (ii) over calendar time and pregnancy stages. Using the hospital discharge records of the national healthcare database, we identified women ending pregnancy at hospital between Dec 27, 2020, i.e. beginning of Covid-19 vaccine availability, and Dec 31, 2022. Covid-19 vaccinations and SARS-CoV-2 infections were also available on two specific linked databases. Vaccine coverage was defined as uptake of at least one dose of vaccine during the 2-year study period, or more specifically during one of five phases of pregnancy (first, second and third trimesters, pre-conceptional and post-pregnancy periods). We also defined ineligibility as the six-month period following each Covid-19 infection. We calculated weekly rates of vaccination by pregnancy phase, accounting for ineligibility. About 75% of women received at least one dose of vaccine in 2021-2022 vs. 90% in the general population with a similar age structure. About 26% received at least one dose of vaccine while pregnant. The rate was lower among younger women, deprived women, and those living in the south-east of mainland France or in overseas territories. Weekly vaccination rates according to the phase of pregnancy showed that women mostly received vaccination outside the pregnancy trimesters (after or, to a less extent, before pregnancy). Vaccinations during pregnancy mostly occurred in the second trimester. When only elective terminations were considered, weekly rates of vaccination were almost identical, whatever the pregnancy phase (before, during or after pregnancy). Overall, our results show the positive impact of national recommendations on uptake dynamics. Vaccine coverage in pregnant women could be improved with targeted campaigns.
More Related Videos
Related Concept Videos
Vaccinations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Principles of Disease Surveillance
Secondary Healthcare System
Teratogenicity
Integrated Healthcare System

